Compliance & EnforcementFalse Claims Act
ArchiveFalse Claims Act
3,592 articles from the Compliance & Enforcement Brief.

Articles

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Application of the Spearin Doctrine Entitles Contractor to Recover FCA Litigation Costs
Tenet Healthcare and Affiliated California Hospital to Pay $1.41 Million to Settle False Claims Act Allegations for Implanting Unnecessary Cardiac Monitors
EHR Vendor Practice Fusion Agrees to $145 Million Settlement to Resolve Criminal and Civil Kickback Violations
Wait a Minute—No Escobar Materiality as to Hospital’s Patient Arrival Time Reports and Employee Handbooks
Teva Pharmaceuticals to Pay $54 Million to Settle Healthcare-Based FCA Claims
Relator Can’t Revive Settled FCA Claims Against Successor Company; United States District Court for the Southern District of Texas No. H-16-0582, U.S. ex rel. Stephanie Schweizer v. Canon Inc., et al.
Absent Evidence of False Claims, Complaint About Regulatory Violation Not Protected Conduct Under FCA; United States District Court for the District of Massachusetts No. 14-13155-PBS, Ebonia Elliott-Lewis v. Abbott Laboratories
Let’s Talk FCA: Top False Claims Act Developments of 2019
Materiality Inquiry Focuses on Likely Reaction of Government to the Receipt of False Claims, Not Mindset of Defendant; United States Court of Appeals for the Tenth Circuit No. 19-3011, U.S. ex rel. Stacey L. Janssen v. Lawrence Memorial Hospital
Relator Substitution Bars Claim Under First-to-File Bar, Blocks Original Relator from Appealing; United States Court of Appeals for the Ninth Circuit No. 18-55643, U.S. ex rel. Alexander Volkhoff LLC v. Janssen Pharmaceutica N.V., et al.
U. S. Settles False Claims Act Allegations Against Southeastern Retina Associates
DOJ’s Procurement Collusion Strike Force Priorities Highlighted By Bid-Rigging Qui Tam Settlement
AseraCare FCA Ruling Is A Boon For Health Providers
Co-Owner of Closely-Held Concern Likely Benefited from Fraud Scheme; United States District Court for the Western District of North Carolina No. 3:17-CV-00037-KDB-DCK, United States ex rel. Taryn Hartnett and Dana Shoched v. Physicians Choice Laboratory, Philip McHugh, et al.
Defendant’s Challenge to Allegedly Vague Regulatory Guidance Fails; United States District Court for the Eastern District of Pennsylvania No. 12-175, 13-1776, U.S. ex rel. Charles Strunck et al. v Mallinckrodt Ard LLC
Protecting Work Product: When the Threat of Litigation Is Too Remote for Privilege
CMS Proposes New Limitations to the Isolated Transactions Exception to the Stark Law
DOJ announces $5.5 Million Settlement with Concerning Allegations of Undisclosed Grants
Nationwide Discovery Inappropriate for Regional FCA Case; United States District Court for the Eastern District of New York No. 14-CV-6646-RRM-SJB, U.S. ex rel. CKD Project LLC v. Fresenius Medical Care AG & Co., et al.
Keep reading


